145 related articles for article (PubMed ID: 25760201)
1. Race influences stage-specific survival in gastric cancer.
Howard JH; Hiles JM; Leung AM; Stern SL; Bilchik AJ
Am Surg; 2015 Mar; 81(3):259-67. PubMed ID: 25760201
[TBL] [Abstract][Full Text] [Related]
2. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
3. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations.
Choi AH; Nelson RA; Merchant SJ; Kim JY; Chao J; Kim J
Gastrointest Endosc; 2016 Jun; 83(6):1184-1192.e1. PubMed ID: 26546980
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database.
Wang J; Sun Y; Bertagnolli MM
Ann Surg Oncol; 2015 Sep; 22(9):2965-71. PubMed ID: 25631065
[TBL] [Abstract][Full Text] [Related]
5. Incorporating surgical quality into the AJCC 7th edition improves staging accuracy in gastric cancer.
Deutsch GB; O'Connor V; Sim MS; Lee JH; Bilchik AJ
Ann Surg Oncol; 2015 Jan; 22(1):11-6. PubMed ID: 25192676
[TBL] [Abstract][Full Text] [Related]
6. Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Jim MA; Pinheiro PS; Carreira H; Espey DK; Wiggins CL; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):4994-5013. PubMed ID: 29205310
[TBL] [Abstract][Full Text] [Related]
7. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.
Kim J; Sun CL; Mailey B; Prendergast C; Artinyan A; Bhatia S; Pigazzi A; Ellenhorn JD
Ann Oncol; 2010 Jan; 21(1):152-60. PubMed ID: 19622590
[TBL] [Abstract][Full Text] [Related]
8. Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Li CI; Malone KE; Daling JR
Arch Intern Med; 2003 Jan; 163(1):49-56. PubMed ID: 12523916
[TBL] [Abstract][Full Text] [Related]
9. Influence of race and sociodemographic factors on declining resection for gastric cancer: A national study.
Schultz KS; de Geus SWL; Sachs TE; Morgan RB; Ng SC; McAneny D; Tseng JF
Am J Surg; 2021 Jan; 221(1):155-161. PubMed ID: 32758359
[TBL] [Abstract][Full Text] [Related]
10. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.
Kapp DS; Shin JY; Chan JK
Cancer; 2008 Feb; 112(4):820-30. PubMed ID: 18189292
[TBL] [Abstract][Full Text] [Related]
12. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
15. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
16. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
17. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
18. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
19. Impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer: analysis for white, African, and East Asian Americans.
Hashiguchi Y; Hase K; Ueno H; Shinto E; Naito Y; Kajiwara Y; Kuroda T; Yamamoto J; Mochizuki H
Ann Surg Oncol; 2012 May; 19(5):1517-28. PubMed ID: 22012028
[TBL] [Abstract][Full Text] [Related]
20. Estimates of conditional survival in gastric cancer reveal a reduction of racial disparities with long-term follow-up.
Luyimbazi D; Nelson RA; Choi AH; Li L; Chao J; Sun V; Hamner JB; Kim J
J Gastrointest Surg; 2015 Feb; 19(2):251-7. PubMed ID: 25421357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
